Recruiting at 1 site No phase Diabetic Peripheral Neuropathy

Clinical trial for Diabetic Peripheral Neuropathy

Official title Combined Effects of INF and OEP in Patients With Diabetic Peripheral Neuropathy

ClinicalTrials.gov ID: NCT07274735

What this study is testing

What it's testing
The study compares two ways to improve balance, reduce pain, and boost daily life for people with diabetic peripheral neuropathy.
Who it's for
Adults who have diabetic peripheral neuropathy and experience balance problems or pain.
What's involved
Participants will receive either INF therapy, which uses manual techniques to improve nerve blood flow, or the Otago Exercise Program, a set of strength and balance exercises, and will be monitored for changes in symptoms.
Time commitment
The study lasts several weeks, with regular visits for treatment sessions and assessments of balance and pain.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 50 to 75

You may be able to join if

  • Age 50-75years
  • Both male and female patients will be included in the study
  • Patient with type 2 diabetes mellitus (diagnosed by the physician)
  • Patients with a score ≥ 4 on DN4 scale
  • Patients have a score on the Timed Up-and-Go (TUG) test of less than 15 s

You likely can't join if

  • Patient with presence of any other systemic disease rather than diabetes such as end-stage renal failure, uncontrolled hypertension, severe...
  • Patients with documented active alcohol or drug misuse
  • Patient with total or partial amputation of lower extremities
  • Participants will be also excluded if they were morbidly obese or if pregnant (self-reported)
  • Patient with active inflammations or other inflammatory neuropathies including chronic inflammatory demyelinating polyneuropathy, proximal diabetic...
See the full eligibility criteria
Who can join
  • Age 50-75years
  • Both male and female patients will be included in the study
  • Patient with type 2 diabetes mellitus (diagnosed by the physician)
  • Patients with a score ≥ 4 on DN4 scale
  • Patients have a score on the Timed Up-and-Go (TUG) test of less than 15 s
  • Able to walk at least 10 meters long
What rules you out
  • Patient with presence of any other systemic disease rather than diabetes such as end-stage renal failure, uncontrolled hypertension, severe dyslipidemia, chronic liver disease, autoimmune disease, advanced chronic...
  • Patients with documented active alcohol or drug misuse
  • Patient with total or partial amputation of lower extremities
  • Participants will be also excluded if they were morbidly obese or if pregnant (self-reported)
  • Patient with active inflammations or other inflammatory neuropathies including chronic inflammatory demyelinating polyneuropathy, proximal diabetic neuropathy, chemotherapy-induced peripheral neuropathy, autonomic...

The study team makes the final eligibility decision.

Where it is enrolling

  • Lahore, Punjab Province, Pakistan

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 50 years to 75 years. The study team makes the final eligibility decision.

Where is this trial taking place?

This study is enrolling now at Lahore, Punjab Province, Pakistan. Enter your location above to see the nearest enrolling site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.